Topical Nitroglycerin: A New and Safe Treatment Option for Osteoporosis
Ayush Agarwal, Omkar Singh, Prabhat Agrawal
Citation Information :
Agarwal A, Singh O, Agrawal P. Topical Nitroglycerin: A New and Safe Treatment Option for Osteoporosis. J South Asian Feder Menopause Soc 2014; 2 (1):20-22.
Applied therapeutics: the clinical use of drugs. Philadelphia: Wolters Kluwer Health/Lippincott Williams and Wilkins. 2009. p. 101-103.
Preventive Services Task, Force (Feb 26, 2013). Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: US Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine 2013;158:691-696.
Osteopaenia in primary healthcare patients: do we need to be more rigorous? Rheumatol Clin 2009;5(1):13-17.
The effects of organic nitrates on osteoporosis: a randomized control trial [ISRCTN94484747]. Trials 2006;7:10.
Osteoporosis-an emerging disease of the 21st century, part 1: An overview. Jfmpc 2012;1(1):66-68.
Rationale for using nitric oxide donor therapy for prevention of bone loss and treatment of osteoporosis in humans. Ann NY Acad Sci 2007 Nov;1117:283-297.
Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia. Bone 2003;32:142-149.
The effects of organic nitrates on osteoporosis: a systematic review. Osteoporos Int 2013 Mar; 24(3):763-770.
Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res 2006;21(11):1811-1817.
Nitric oxide synthase: models and mechanisms. Current Opinion in Chemical Biology 2000 Dec;4(6):687-695.
Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss; a human pilot clinical study. J Bone Miner Res 2000 Nov;15(11):2240-2244.
